Bristol Myers Squibb (BMY) Change in Accrued Expenses (2021 - 2026)
Bristol Myers Squibb (BMY) recorded Change in Accrued Expenses of -$734 million in Q3 2026, compared with $1.7 billion a year earlier.
Bristol Myers Squibb (BMY) Change in Accrued Expenses (2021 - 2026) Analysis & Trends
On a TTM basis, Bristol Myers Squibb's Change in Accrued Expenses came in at -$6.27 billion as of Sep 30, 2026; for FY2025, it came in at -$441 million.
- Across earlier years, Change in Accrued Expenses came in at $1.48 billion in FY2024 (+64.2%), $904 million in FY2023 (+111.7%), $427 million in FY2022 (-50.5%) and $863 million in FY2021 (-27.4%).
- Quarterly Change in Accrued Expenses has ranged from -$3.5 billion in Q1 2026 to $1.82 billion in Q3 2024 over the past five years.
- Peak year-over-year performance for Change in Accrued Expenses in the last five years was growth of 141.9% in Q2 2022, against a decline of 59.1% in Q2 2026 at the low end.
- Per Business Quant, the preceding three quarters came in at $360 million (Q2 2026), -$3.5 billion (Q1 2026) and -$2.4 billion (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Accrued Exp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,276.89 Bn | 1,250.50 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 681.31 Bn | 601.18 Bn | 17.30 Bn | 2.41 Bn |
| 3 | AbbVie | 520.63 Bn | 488.64 Bn | 13.12 Bn | 983.00 Mn |
| 4 | Merck | 357.22 Bn | 320.16 Bn | 13.19 Bn | - |
| 5 | Novartis Ag | 310.90 Bn | 284.14 Bn | - | - |
| 6 | Astrazeneca | 285.12 Bn | 258.77 Bn | 13.26 Bn | - |
| 7 | Amgen | 250.23 Bn | 201.89 Bn | 7.58 Bn | -87.00 Mn |
| 8 | Gilead Sciences | 207.56 Bn | 182.67 Bn | 6.73 Bn | 756.00 Mn |
| 9 | Pfizer | 164.42 Bn | 111.77 Bn | 12.56 Bn | - |
| 10 | Bristol Myers Squibb | 128.63 Bn | 83.82 Bn | 8.92 Bn | -734.00 Mn |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -734.00 Mn |
| Jun 30, 2026 | 360.00 Mn |
| Mar 31, 2026 | -3.50 Bn |
| Dec 31, 2025 | -2.40 Bn |
| Sep 30, 2025 | 1.70 Bn |
| Jun 30, 2025 | 881.00 Mn |
| Mar 31, 2025 | -627.00 Mn |
| Dec 31, 2024 | -405.00 Mn |
| Sep 30, 2024 | 1.82 Bn |
| Jun 30, 2024 | 735.00 Mn |
| Mar 31, 2024 | -665.00 Mn |
| Dec 31, 2023 | -211.00 Mn |
| Sep 30, 2023 | 1.53 Bn |
| Jun 30, 2023 | 492.00 Mn |
| Mar 31, 2023 | -910.00 Mn |
| Dec 31, 2022 | -303.00 Mn |
| Sep 30, 2022 | 1.14 Bn |
| Jun 30, 2022 | 520.00 Mn |
| Mar 31, 2022 | -930.00 Mn |
| Dec 31, 2021 | -39.00 Mn |
Bristol Myers Squibb Change in Accrued Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=BMY&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "change-in-accured-expenses", "ticker": "BMY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=BMY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();